Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients

被引：0
|
作者：
Terrault, NA
Wright, TL
Roberts, JP
Ascher, NL
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] VAMC, San Francisco, CA USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
905
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [21] The pharmacokinetic profile of low dose intramuscular (IM) hepatitis B immune globulin (HBIG) in long-term HBV liver transplant recipients.
    Yoshida, EM
    Guy, MW
    Ensom, MM
    Nobel, MA
    Partovi, N
    HEPATOLOGY, 2000, 32 (04) : 292A - 292A
  • [22] Efficacy of combined lamivudine (LAM) and hepatitis B immunoglobulin (HBIg) for the prevention of hepatitis B recurrence after liver transplantation (LT): Birmingham experience.
    Bizollon, T
    Gunson, B
    Dudley, T
    Haydon, G
    Mutimer, D
    LIVER TRANSPLANTATION, 2006, 12 (05) : C20 - C20
  • [23] Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation
    Naoumov, NV
    Lopes, AR
    Burra, P
    Caccamo, L
    Iemmolo, RM
    de Man, RA
    Bassendine, M
    O'Grady, JG
    Portmann, BC
    Anschuetz, G
    Barrett, CA
    Williams, R
    Atkins, M
    JOURNAL OF HEPATOLOGY, 2001, 34 (06) : 888 - 894
  • [24] Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors
    Shen, Yaoyao
    Qi, Jiaqian
    Wang, Yi
    Chen, Jia
    Fan, Yi
    Wang, Ying
    Wu, Depei
    Xu, Yang
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2284 - 2287
  • [25] Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or no therapy in preventing hepatitis B (HBV) recurrence after liver transplantation (LT)
    Andreone, P
    Grazi, GL
    Gramenzi, A
    Cursaro, C
    Biselli, M
    Caraceni, P
    Morelli, MC
    Sama, C
    Iovine, E
    Del Gaudio, M
    Bellusci, R
    Mazziotti, A
    Cavallari, A
    Bernardi, M
    JOURNAL OF HEPATOLOGY, 2000, 32 : 51 - 51
  • [26] EFFICACY AND COST OF LONG-TERM INTRAMUSCULAR HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN LIVER-TRANSPLANTATION (LT) FOR HEPATITIS-B
    VILLAMIL, FG
    PAN, SH
    KUHNS, MC
    PODESTA, LG
    SHER, L
    MAKOWKA, L
    VIERLING, JM
    HEPATOLOGY, 1994, 20 (04) : A129 - A129
  • [27] Is lamivudine with one-week HBIg as effective as long-term high dose HBIg in the HBV prophylaxis after liver transplantation?
    Park, SJ
    Paik, SW
    Choi, MS
    Lee, JH
    Koh, KC
    Kim, SJ
    Joh, JW
    Lee, SK
    JOURNAL OF HEPATOLOGY, 2001, 34 : 2 - 2
  • [28] Prophylaxis of hepatitis B reinfection after liver transplantation with HBIg and lamivudine.
    Rosenau, J
    Bahr, MJ
    Tillmann, HL
    Klempnauer, J
    Manns, MP
    Boeker, KH
    GASTROENTEROLOGY, 2000, 118 (04) : A1483 - A1483
  • [29] Inter- and intra-individual consumption of hepatitis B immunoglobulins (HBIG) in liver transplant recipients receiving HBIG and lamivudine to prevent recurrent HBV infection
    Angelico, M
    Di Paolo, D
    Trinito, G
    Torri, E
    Araco, A
    Lionetti, R
    Casciani, CU
    Tisone, G
    JOURNAL OF HEPATOLOGY, 2001, 34 : 9 - 9
  • [30] HEPATITIS-B HYPERIMMUNOGLOBULIN (HBIG) PROPHYLAXIS AFTER HEPATITIS-B VIRUS (HBV) EXPOSURE
    HUSSAIN, SI
    BUTT, MR
    POTZI, R
    DRAGOSICS, B
    CENTRAL AFRICAN JOURNAL OF MEDICINE, 1986, 32 (01) : 1 - 2
12345